May 10, 2022 / 04:20PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Healthcare Conference live in Las Vegas. I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst for those of you who don't know me. And our next company is Avantor. And with us today is Michael Stubblefield, President and CEO of Avantor and a company that's come a long way since the IPO. We did gosh, it was like, what, 3 years ago?
Michael Stubblefield - Avantor, Inc. - President, CEO & Director
Going upon our 3-year anniversary next week.
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Time flies in the pandemic.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchSo I'm feeling generous this morning, so I'm going to give you an easy question to start. We -- when we hosted you at our fireside chat at our virtual conference last year, we were still doing a lot of education on the basic of Avantor
Trustpilot
